podcast

R&D

Big data and cell therapy development: the pharmaphorum podc...

In the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr Darrin Disley, who's the CEO of Mogrify.

R&D

GSK on COVID and vaccine development: the pharmaphorum podca...

In the latest episode of the pharmaphorum podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery and commercialisation of new vaccines in the light of the pandem

Digital

The meaning of digital innovation: the pharmaphorum podcast

This instalment of the podcast considers the meaning of digital innovation, both in pharma and outside the industry, and features digital transformation leader Edwin Erckens.

R&D

New ways to treat COVID: the pharmaphorum podcast

In episode 31 of the pharmaphorum podcast, Deep Dive editor George Underwood speaks to RedHill biopharma’s chief business officer Guy Goldb

R&D

Roche on COVID-19 healthcare and testing: the pharmaphorum p...

For episode 30 I spoke with Dr Ashton Harper, who’s head of medical affairs in the UK and Ireland at Roche Diagnostics, about the pressure COVID-19 has put on healthcare systems.

R&D

Richard Francis on his Purespring plans: the pharmaphorum po...

In this episode of the pharmaphorum podcast, our news editor Richard Staines talks to Richard Francis, who took over as CEO of gene therapy company Purespring Therapeutics earlier this mont